Citigroup Inc Siga Technologies Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Siga Technologies Inc stock. As of the latest transaction made, Citigroup Inc holds 51,155 shares of SIGA stock, worth $306,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,155

Previous 11,781 334.22%

Holding current value

$306,930

Previous $89,000 286.52%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$6.74 - $11.97 $265,380 - $471,306	39,374 Added 334.22%	51,155 $344,000
Q2 2024 Aug 12, 2024	BUY	$6.32 - $10.46 $23,997 - $39,716	3,797 Added 47.56%	11,781 $89,000
Q1 2024 May 10, 2024	BUY	$4.51 - $8.92 $577 - $1,141	128 Added 1.63%	7,984 $68,000
Q4 2023 Feb 09, 2024	BUY	$4.82 - $6.25 $31,619 - $41,000	6,560 Added 506.17%	7,856 $43,000
Q3 2023 Nov 09, 2023	SELL	$4.32 - $5.77 $63,231 - $84,455	-14,637 Reduced 91.87%	1,296 $6,000
Q2 2023 Aug 10, 2023	BUY	$5.0 - $6.31 $69,995 - $88,333	13,999 Added 723.84%	15,933 $80,000
Q1 2023 May 11, 2023	SELL	$5.23 - $8.42 $78,465 - $126,325	-15,003 Reduced 88.58%	1,934 $11,000
Q4 2022 Feb 09, 2023	SELL	$7.29 - $10.14 $58,232 - $80,998	-7,988 Reduced 32.05%	16,937 $124,000
Q3 2022 Nov 10, 2022	BUY	$10.02 - $26.15 $170,169 - $444,105	16,983 Added 213.84%	24,925 $257,000
Q2 2022 Aug 10, 2022	SELL	$6.5 - $13.68 $9,860 - $20,752	-1,517 Reduced 16.04%	7,942 $92,000
Q1 2022 May 12, 2022	SELL	$5.96 - $7.61 $33,376 - $42,616	-5,600 Reduced 37.19%	9,459 $67,000
Q4 2021 Feb 10, 2022	BUY	$6.96 - $9.26 $33,129 - $44,077	4,760 Added 46.22%	15,059 $113,000
Q3 2021 Nov 10, 2021	BUY	$5.71 - $7.39 $58,807 - $76,109	10,299 New	10,299 $76,000

Others Institutions Holding SIGA

# of Institutions

185

Shares Held

35.6M

Call Options Held

873K

Put Options Held

466K

View Full List

About SIGA TECHNOLOGIES INC

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

More about SIGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account